CSPC Innovation Pharmaceutical Second Quarter 2024 Earnings EPS CN0.043 - Simply Wall St
| IPIX Stock | USD 0.0003 0.0001 25.00% |
Slightly above 62% of Innovation Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Innovation Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Innovation Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Innovation Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Innovation |
CSPC Innovation Pharmaceutical Second Quarter 2024 Earnings EPS CN0.043 Simply Wall St
Read at news.google.com
 |
Innovation Pharmaceuticals Fundamental Analysis
We analyze Innovation Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Innovation Pharmaceuticals is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Innovation Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innovation Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Innovation Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Innovation Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Innovation Pharmaceuticals Related Equities
| HYEX | Grey Cloak | 25.00 |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.